Attached files
file | filename |
---|---|
10-K - FORM 10-K - CALYPTE BIOMEDICAL CORP | calypte_10k-123109.htm |
EX-23.1 - EXHIBIT 23.1 - CALYPTE BIOMEDICAL CORP | ex23-1.htm |
EX-21.1 - EXHIBIT 21.1 - CALYPTE BIOMEDICAL CORP | ex21-1.htm |
EX-31.1 - EXHIBIT 31.1 - CALYPTE BIOMEDICAL CORP | ex31-1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18 U.S.C.
SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
The
undersigned hereby certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the
Annual Report on Form 10-K of Calypte Biomedical Corporation (the
“Company”) for the year ended December 31, 2010 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934 and that information contained in such report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.
March 30,
2010
/s/ Adel
Karas
Adel
Karas
President,
Chief Executive Officer and Chief Financial Officer (Principal Executive and
Financial Officer)